We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Gestational weight gain, appetite‐regulating hormones and metformin treatment in polycystic ovary syndrome: The importance of exclusion criteria.
- Authors
Zehra, Syeda Alishah; Shah, Hussain Haider
- Abstract
Gestational weight gain, appetite-regulating hormones and metformin treatment in polycystic ovary syndrome: The importance of exclusion criteria REFERENCES 1 Molin J, Vanky E, Løvvik TS, Dehlin E, Bixo M. Gestational weight gain, appetite regulating hormones, and metformin treatment in polycystic ovary syndrome: a longitudinal, placebo-controlled study. Studies concur with the findings that metformin reduces the risk for excessive GWG and improves physiological leptin resistance in pregnant women with PCOS.[2] In the original article, the authors mainly emphasised the effects of metformin on GWG and maternal appetite-regulating hormones, but did not explore the possible effects of metformin on fetal hormones due to intrauterine metformin exposure.
- Subjects
POLYCYSTIC ovary syndrome; WEIGHT gain; METFORMIN; FETAL macrosomia; HORMONES
- Publication
BJOG: An International Journal of Obstetrics & Gynaecology, 2023, Vol 130, Issue 7, p840
- ISSN
1470-0328
- Publication type
Article
- DOI
10.1111/1471-0528.17367